购物车
您的购物车当前为空
Anti-PIK3CA Monoclonal Antibody (7T396) 是一种 Mouse 抗体,靶向 PIK3CA。Anti-PIK3CA Monoclonal Antibody (7T396) 可用于 IHC,IF,FCM。
别名 PI3K, p110-alpha
Anti-PIK3CA Monoclonal Antibody (7T396) 是一种 Mouse 抗体,靶向 PIK3CA。Anti-PIK3CA Monoclonal Antibody (7T396) 可用于 IHC,IF,FCM。

TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Anti-PIK3CA Monoclonal Antibody (7T396) is a Mouse antibody targeting PIK3CA. Anti-PIK3CA Monoclonal Antibody (7T396) can be used in IHC,IF,FCM. |
| 别名 | PI3K, p110-alpha |
| Ig Type | IgG2a |
| 克隆号 | 7T396 |
| 反应种属 | Human,Mouse,Rat,Rabbit |
| 应用 | IHCIFFCM |
| 推荐剂量 | IHC: 1/200-1/1000; IF: 1/200-1/1000; FCM: 1/200-1/400 |
| 抗体种类 | Monoclonal |
| 宿主来源 | Mouse |
| 构建方式 | Hybridoma Monoclonal Antibody |
| 纯化方式 | Purified by protein A or protein G |
| 性状 | Liquid |
| 缓冲液 | PBS with 0.05% sodium azide. |
| 浓度 | 1 mg/mL |
| 研究背景 | PIK3CA is the most mutated gene in breast cancer and is important in other cancers. An integral part of the PI3K pathway, PIK3CA is an oncogene with two hotspots for activating mutations: the 542/545 region of the helical domain and the 1047 region of the kinase domain. The interaction of PIK3CA with the AKT and mTOR pathways is the subject of an immense amount of research and development, and PI3K inhibitors have exhibited some success in recent clinical trials. While PI3K monotherapies are likely insufficient, there is interest in pursuing PI3K inhibition in combination with other therapies including TKI's, MEK inhibitors, PARP inhibitors, and - in breast cancer - aromatase inhibitors. |
| 偶联 | Unconjugated |
| 免疫原 | Purified recombinant fragment of human PIK3CA expressed in E. Coli. |
| 抗原种属 | Human |
| 基因名称 | PIK3CA |
| 基因ID | |
| 蛋白名称 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform |
| Uniprot ID |
| 储存方式 | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| 运输方式 | Shipping with blue ice. |